Clin2
NCT06847178Possibly a fitNot yet recruiting

Study of LC-Z300-01 for adults with type 2 diabetes

DiabetesType 2 Diabetes

Part of Hormones & metabolism clinical trials.

This study tests a new medicine called LC-Z300-01 to see if it is safe and works well for people with type 2 diabetes. It may help lower blood sugar levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with type 2 diabetes.
  • Your body mass index (BMI) is between 18 and 35.
  • Your HbA1c (average blood sugar over 3 months) is between 7.5% and 9.0%.
  • You have been taking the same diabetes medicines (pills, insulin, or GLP-1 injections) for at least 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07379333Recruiting· Phase 3
Testing a new drug for type 2 diabetes when metformin and dapagliflozin aren't enough

This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.

Gyeonggi-do
NCT07193459Recruiting· Phase 3
Study of an oral tablet for type 2 diabetes

This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.

Beijing, Beijing Municipality
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing
NCT06829563Recruiting· Phase 1
Testing safety of new diabetes drug RZ-629

This early-phase study tests a new medicine called RZ-629. It looks at how safe it is, how the body processes it, and how it works in both healthy people and people with type 2 diabetes. If you have diabetes, you can join if your blood sugar is well controlled on your current pills.

Adelaide
NCT06974487Not yet recruiting· Phase 1
Weight management study for overweight adults

This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.

Beijing
NCT07568678Recruiting· Phase 1
Testing HMS1005 in adults with type 2 diabetes

This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.

Miami, Florida

Hear when a new Diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.